Revenue
$69.67B
Fiscal year ended 2025-08-31Operating income
$10.23B
Fiscal year ended 2025-08-31Free cash flow
$10.87B
Fiscal year ended 2025-08-31Accenture plc (ACN) reported revenue of $69.67B and net income of $7.68B for the fiscal year ended 2025-08-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from Accenture plc’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Services-Business Services, NEC.
Income
| Metric | 2025-08-31 | 2024-08-31 | 2023-08-31 | 2022-08-31 | 2021-08-31 | 2020-08-31 | 2019-08-31 | 2018-08-31 | 2017-08-31 | 2016-08-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $69.67B | $64.90B | $64.11B | $61.59B | $50.53B | $44.33B | $43.22B | $40.99B | $36.18B | $34.80B |
| Cost of revenue | $47.44B | $43.73B | $43.38B | $41.89B | $34.17B | $30.35B | $29.90B | $28.50B | $25.11B | $24.52B |
| Gross profit | $22.24B | $21.16B | $20.73B | $19.70B | $16.36B | $13.98B | $13.31B | $12.49B | $11.07B | $10.28B |
| Operating income | $10.23B | $9.60B | $8.81B | $9.37B | $7.62B | $6.51B | $6.31B | $5.90B | $5.19B | $4.81B |
| Net income | $7.68B | $7.26B | $6.87B | $6.88B | $5.91B | $5.11B | $4.78B | $4.06B | $3.45B | $4.11B |
| Research & development | $817.30M | $1.15B | $1.30B | $1.12B | $1.12B | $870.61M | $799.73M | $790.78M | $704.32M | $643.41M |
| Weighted-average diluted shares | shares 632.44M | shares 635.94M | shares 638.59M | shares 642.84M | shares 645.91M | shares 647.80M | shares 650.20M | shares 655.30M | shares 660.46M | shares 667.77M |
| Pretax income | $10.27B | $9.70B | $9.14B | $9.20B | $7.76B | $6.77B | $6.25B | $5.81B | $4.62B | $5.60B |
| Income tax expense | $2.44B | $2.28B | $2.14B | $2.21B | $1.77B | $1.59B | $1.41B | $1.59B | $981.10M | $1.25B |
| Diluted EPS | $12.15 | $11.44 | $10.77 | $10.71 | $9.16 | $7.89 | $7.36 | $6.34 | $5.44 | $6.45 |
| Selling, general & administrative | $11.39B | $11.13B | $10.86B | $10.33B | $8.74B | $7.46B | $7.01B | $6.59B | $5.88B | $5.47B |
| General & administrative | $4.35B | $4.28B | $4.28B | $4.23B | $3.45B | $2.84B | $2.56B | $2.40B | $2.13B | $1.89B |
| Selling & marketing | $7.04B | $6.85B | $6.58B | $6.11B | $5.29B | $4.63B | $4.45B | $4.20B | $3.75B | $3.58B |
Balance
| Metric | 2025-08-31 | 2024-08-31 | 2023-08-31 | 2022-08-31 | 2021-08-31 | 2020-08-31 | 2019-08-31 | 2018-08-31 | 2017-08-31 | 2016-08-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $11.48B | $5.00B | $9.05B | $7.89B | $8.17B | $8.42B | $6.13B | $5.06B | $4.13B | $4.91B |
| Total assets | $65.39B | $55.93B | $51.25B | $47.26B | $43.18B | $37.08B | $29.79B | $24.45B | $22.69B | $20.61B |
| Current assets | $28.90B | $20.86B | $23.38B | $21.61B | $19.67B | $17.75B | $15.45B | $13.59B | $12.10B | $11.98B |
| Total liabilities | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Current liabilities | $20.35B | $18.98B | $18.01B | $17.52B | $15.71B | $12.66B | $11.06B | $10.15B | $9.82B | $8.88B |
| Total equity incl. NCI | $32.24B | $29.17B | $26.46B | $22.75B | $20.10B | $17.50B | $14.83B | $10.72B | $9.71B | $8.19B |
| Temporary (mezzanine) equity | $0 | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Accounts receivable | $13.07B | $11.87B | $10.69B | $10.48B | $8.80B | $7.19B | $7.47B | $5.00B | $4.57B | $4.07B |
| Goodwill | $22.54B | $21.12B | $15.57B | $13.13B | $11.13B | $7.71B | $6.21B | $5.38B | $5.00B | $3.61B |
| Long-term debt | $5.03B | $78.63M | $43.09M | $45.89M | $53.47M | $54.05M | $16.25M | $19.68M | $22.16M | $24.46M |
| Accounts payable | $2.70B | $2.74B | $2.49B | $2.56B | $2.27B | $1.35B | $1.65B | $1.35B | $1.53B | $1.28B |
Cash flow
| Metric | 2025-08-31 | 2024-08-31 | 2023-08-31 | 2022-08-31 | 2021-08-31 | 2020-08-31 | 2019-08-31 | 2018-08-31 | 2017-08-31 | 2016-08-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $11.47B | $9.13B | $9.52B | $9.54B | $8.98B | $8.22B | $6.63B | $6.03B | $4.97B | $4.67B |
| Capital expenditures | $600.04M | $516.51M | $528.17M | $718.00M | $580.13M | $599.13M | $599.01M | $619.19M | $515.92M | $496.57M |
| Investing cash flow | -$2.02B | -$7.06B | -$2.62B | -$4.26B | -$4.31B | -$1.89B | -$1.76B | -$1.25B | -$2.23B | -$610.35M |
| Financing cash flow | -$2.95B | -$6.06B | -$5.65B | -$5.31B | -$4.93B | -$4.05B | -$3.77B | -$3.71B | -$3.56B | -$3.49B |
| Net change in cash | $6.47B | -$4.04B | $1.16B | -$278.34M | -$247.16M | $2.29B | $1.07B | $934.50M | -$778.75M | $544.84M |
| Stock-based compensation | $2.09B | $1.94B | $1.91B | $1.68B | $1.34B | $1.20B | $1.09B | $976.91M | $795.24M | $758.18M |
| Common dividends paid | $3.70B | $3.24B | $2.83B | $2.46B | $2.24B | $2.04B | $1.86B | $1.71B | $1.57B | $1.44B |
| Common share repurchases | $4.62B | $4.52B | $4.33B | $4.12B | $3.70B | $2.92B | $2.69B | $2.64B | $2.65B | $2.60B |
| Depreciation & amortization | Unavailable | $1.44B | $1.41B | $1.32B | $1.13B | $1.02B | $892.76M | $926.78M | $801.79M | $729.05M |
Derived
| Metric | 2025-08-31 | 2024-08-31 | 2023-08-31 | 2022-08-31 | 2021-08-31 | 2020-08-31 | 2019-08-31 | 2018-08-31 | 2017-08-31 | 2016-08-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $10.87B | $8.61B | $9.00B | $8.82B | $8.40B | $7.62B | $6.03B | $5.41B | $4.46B | $4.17B |
| Gross margin | 31.9% | 32.6% | 32.3% | 32.0% | 32.4% | 31.5% | 30.8% | 30.5% | 30.6% | 29.5% |
| Operating margin | 14.7% | 14.8% | 13.7% | 15.2% | 15.1% | 14.7% | 14.6% | 14.4% | 14.4% | 13.8% |
| FCF margin | 15.6% | 13.3% | 14.0% | 14.3% | 16.6% | 17.2% | 13.9% | 13.2% | 12.3% | 12.0% |
| SBC / revenue | 3.0% | 3.0% | 3.0% | 2.7% | 2.7% | 2.7% | 2.5% | 2.4% | 2.2% | 2.2% |
| Current ratio | 1.42x | 1.10x | 1.30x | 1.23x | 1.25x | 1.40x | 1.40x | 1.34x | 1.23x | 1.35x |
| Revenue YoY growth | 7.4% | 1.2% | 4.1% | 21.9% | 14.0% | 2.6% | 5.4% | 13.3% | 4.0% | Unavailable |
| Net margin | 11.0% | 11.2% | 10.7% | 11.2% | 11.7% | 11.5% | 11.1% | 9.9% | 9.5% | 11.8% |
| R&D / revenue | 1.2% | 1.8% | 2.0% | 1.8% | 2.2% | 2.0% | 1.9% | 1.9% | 1.9% | 1.8% |
| CapEx / revenue | 0.9% | 0.8% | 0.8% | 1.2% | 1.1% | 1.4% | 1.4% | 1.5% | 1.4% | 1.4% |
| Long-term debt / equity | 0.16x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 23.7% | 23.5% | 23.4% | 24.0% | 22.8% | 23.5% | 22.5% | 27.4% | 21.3% | 22.4% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open ACN in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-06-18View SEC filing
10-Q · Filed 2026-03-19View SEC filing
10-Q · Filed 2025-12-18View SEC filing
10-K · Filed 2025-10-10View SEC filing
10-Q · Filed 2025-06-20View SEC filing
10-Q · Filed 2025-03-20View SEC filing
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.